EGFR and cancer: Furthermore, next-generation sequencing (NGS) was performed using tissue sample (tumor cellularity 70%, including 168 cancer-related genes; Burning Rock, Beijing, China) showed EGFR exon 19 p.E746_S752delinsV in-frame deletion (frequency as 30.67%) caused by c.2237_2255delinsT mutation.